Improved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancer

J. Roperch, K. Benzekri, H. Mansour, R. Incitti
BMC Biotechnology (in press), (2015)

Improved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancer

Keywords

Spermidine, Colorectal cancer, QM-MSP, Methylated biomarkers

Abstract

​Background

Using quantitative methylation-specific PCR (QM-MSP) is a promising method for colorectal cancer (CRC) diagnosis from stool samples. Difficulty in eliminating PCR inhibitors of this body fluid has been extensively reported. Here, spermidine is presented as PCR facilitator for the detection of stool DNA methylation biomarkers using QM-MSP. We examined its effectiveness with NPY, PENK and WIF1, three biomarkers which we have previously shown to be of relevance to CRC.

Results

We determined an optimal window for the amplification of the albumin (Alb) gene (100 ng of bisulfite-treated stool DNA added of 1 mM spermidine) at which we report that spermidine acts as a PCR facilitator (AE = 1680%) for SG RT-PCR. We show that the amplification of methylated PENK, NPY and WIF1 is considerably facilitated by QM-MSP as measured by an increase of CMI (Cumulative Methylation Index, i.e. the sum of the three methylation values) by a factor of 1.5 to 23 fold in individual samples, and of 10 fold in a pool of five samples.

Conclusions

We contend that spermidine greatly reduces the problems of PCR inhibition in stool samples. This observed feature, after validation on a larger sampling, could be used in the development of stool-based CRC diagnosis tests.

Code

DOI: 10.1186/s12896-015-0148-6

Sources

Website PDF

See all publications 2015